Yahoo
OTC Markets OTCQB - Delayed Quote USD

Ocumetics Technology Corp. (OTCFF)

0.2887 0.0000 (0.00%)
As of November 3 at 4:00:00 PM EST. Market Open.
Chart Range Bar
Loading chart for OTCFF
  • Previous Close 0.2887
  • Open 0.2890
  • Bid 0.2801 x 747600
  • Ask 0.3604 x 500000
  • Day's Range 0.2890 - 0.2890
  • 52 Week Range 0.2600 - 0.7900
  • Volume 4,026
  • Avg. Volume 5,572
  • Market Cap (intraday) 38.803M
  • Beta (5Y Monthly) 0.26
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0400
  • Earnings Date (est.) Nov 24, 2026
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Ocumetics Technology Corp. engages in research, development, production, and sale of vision enhancement products in Canada. It develops expandable intraocular lenses to eliminate the need for corrective lenses primarily for people over 45 years of age. The company was formerly known as Quantum Blockchain Technologies Ltd. and changed its name to Ocumetics Technology Corp. in August 2021. The company was founded in 2012 and is headquartered in Calgary, Canada.

ocumetics.com

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/4/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

OTCFF
36.26%
S&P/TSX Composite index (^GSPTSE)
14.01%

1-Year Return

OTCFF
64.61%
S&P/TSX Composite index (^GSPTSE)
20.00%

3-Year Return

OTCFF
31.26%
S&P/TSX Composite index (^GSPTSE)
83.26%

5-Year Return

OTCFF
31.26%
S&P/TSX Composite index (^GSPTSE)
70.23%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -295.42%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -7.57M

  • Diluted EPS (ttm)

    -0.0400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    88.74k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -1.77M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: